<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.
Contact Us
Contact Us

Parkinson's Disease

SPEAK WITH A SCIENTIST

mdbiosciences-neurology-leading-preclinical-CRO-1

Advancing Preclinical Research with Parkinson's Disease Models

MD Biosciences provides comprehensive Parkinson’s disease animal models, including MPTP and 6-OHDA neurotoxin models, along with advanced genetic approaches. These models yield critical insights into neurodegeneration and pain, supporting the development of more effective therapies.
Speak with a scientist
 
Scientific Data

Endpoint Analysis in MPTP

The figure shows reduced TH staining in the SNpc in the MPTP rodent model, indicating dopaminergic neuron loss in the disease model.

DOWNLOAD DATASHEET
Immunohistochemical staining for Tyrosine Hydroxylase in SNpc

Assessments

MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.
behavior

Behavior 

Conduct extensive pain, sensory, motor, and cognitive behavioral testing.

biomarker

Biomarkers

Explore inflammatory and pain biomarkers in disease-specific tissues.

histology

Histology

Characterize tissue and cellular changes in disease, pain, and neurodegeneration.

READY TO DISCUSS YOUR PROGRAM?

MD Biosciences is your dedicated partner in drug development, offering tailored study designs, translational models, and comprehensive endpoints. With short lead times, competitive pricing, and deep scientific expertise, we help move your pipeline forward efficiently.

Request Proposal